vimarsana.com
Home
Live Updates
Ad Scientiam - Breaking News
Pages:
Latest Breaking News On - Ad scientiam - Page 1 : vimarsana.com
Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases
Ad Scientiam, launches programs to develop and validate novel digital biomarkers for the self-assessment of patients suffering from generalized myasthenia gravis and neuromyelitis optica spectrum disorders
Privacy policy
Ad scientiam
Digital biomarkers
Generalized myasthenia gravis
Neuromyelitis optica spectrum
Ealth press release
Investegate |Ad Scientiam Announcements | Ad Scientiam: Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases
Investegate announcements from Ad Scientiam, Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases
France general
Saad zina
Guido sabatella
Paris brain institute
Develop digital biomarkers
Chronic neurological
Rare disease day
Astrazeneca rare
Global medical lead
Matthieu lamy
Quantitative myasthenia gravis
Chief medical
Investegate announcements
Investegate company announcements
Ad scientiam
Lobenewswire and globenewswire
vimarsana © 2020. All Rights Reserved.